Photys Therapeutics Debuts With $75 Million Series A Funding To Advance New Class Of Bifunctional Molecules For Precision Phosphorylation To Modulate And Repair Disease-Driving Proteins
Amount Raised
$75 Million
Round Type
Series A
CambridgeBiotechnologyHealth CareGeneticsTherapeuticsDescription
Photys Therapeutics, the pioneer in the development of phosphorylation-inducing chimeric small molecule medicines (PHICS), founded by Longwood Fund and Dr. Amit Choudhary of Brigham and Women’s Hospital and the Broad Institute of MIT and Harvard, today announced a $75 million Series A financing led by MPM Capital and joined by Omega Funds, Longwood, 8VC, Arkin Bio, Mass General Brigham Ventures, MRL Ventures Fund, the therapeutics-focused corporate venture fund of Merck & Co., Eli Lilly and Company, and Heritage Medical Systems. Through induced proximity, PHICS enhance the pairing of specific kinases, the enzymes responsible for protein phosphorylation, with disease target proteins, unlocking a new approach to treatment of underserved diseases.
Quick answer
Photys Therapeutics raised $75 Million in a Series A round, dated September 8, 2022. Photys Therapeutics is based in Cambridge, Maryland, United States.
- How much did Photys Therapeutics raise?
- Photys Therapeutics raised $75 Million in a Series A round on September 8, 2022.
- What does Photys Therapeutics do?
- Photys Therapeutics, founded by Longwood Fund and Dr. Amit Choudhary of Brigham and Women’s Hospital and the Broad Institute of MIT and Harvard, is advancing Phosphorylation Inducing Chimeric Small Molecules (PHICS), a..
- Where is Photys Therapeutics based and how big is it?
- Photys Therapeutics is based in Cambridge, Maryland, United States.
Source: Fundz verified event record.
Who else raised in Genetics and Therapeutics around the same time
Companies in the same sectors as Photys Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Inherent Biosciences raised an undisclosed amount (Series A) on September 7, 2022.
- Inherent Biosciences raised $1.5M (Seed) on August 19, 2022.
- MeiraGTx Holdings plc raised an undisclosed amount (Debt Financing) on August 3, 2022.
- Elevation Oncology raised $50M (Debt Financing) on July 28, 2022.
- Insmed Incorporated raised an undisclosed amount (Funding Round) on October 19, 2022.
- Orionis Biosciences raised $55M (Funding Round) on October 19, 2022.
Who to call at Photys Therapeutics, and when
A new round usually means Photys Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Photys Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Photys Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Photys Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Photys Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansPhotys Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.